Edgewise Therapeutics EWTX
NASDAQ EWTX
$47.57 +1.04 (+2.24%)
As of: Nov 11, 2026 · 3:59 PM EST

Edgewise Therapeutics (EWTX) Return on Equity [ROE] (2021 - 2026)

Updated

Edgewise Therapeutics (EWTX) reported Return on Equity [ROE] of -41.91% for Q2 2026, down 12.32 percentage points from -29.58% a year earlier and down 7.24 percentage points from the prior quarter.

Analysis

Edgewise Therapeutics (EWTX) Return on Equity [ROE] (2021 - 2026) Analysis & Trends

For FY2025, Edgewise Therapeutics posted Return on Equity [ROE] of -34.19%, up 0.20 percentage points from FY2024.

  • Return on Equity [ROE] has a four-year change of +1.34 percentage points (FY2021 to FY2025).
  • By year, Return on Equity [ROE] came in at -34.40% in FY2024 (-4.30 pp), -30.10% in FY2023 (-8.32 pp), -21.78% in FY2022 (+13.75 pp) and -35.53% in FY2021.
  • The Q2 2026 figure ranks as the lowest quarterly Return on Equity [ROE] in data going back to Q1 2021.
  • Year over year, Return on Equity [ROE] has now declined in each of the last six quarters, with an average year-over-year change of -3.18 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Equity [ROE] in five years was Q3 2024 (a gain of 4.84 percentage points); the low point was Q4 2023 (a drop of 13.78 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -34.67% (Q1 2026), -31.05% (Q4 2025) and -27.40% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 74.39%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 19.33%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 5.63%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 21.60%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 72.13%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -31.17%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 4.66%
10 Edgewise Therapeutics 5.09 Bn 2.32 Bn - 96.44%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 96.44%
Jun 30, 2026 -42.05%
Mar 31, 2026 -34.79%
Dec 31, 2025 -31.00%
Sep 30, 2025 -27.46%
Jun 30, 2025 -29.34%
Mar 31, 2025 -32.58%
Dec 31, 2024 -28.16%
Sep 30, 2024 -24.58%
Jun 30, 2024 -22.27%
Mar 31, 2024 -24.94%
Dec 31, 2023 -32.40%
Sep 30, 2023 -29.14%
Jun 30, 2023 -24.81%
Mar 31, 2023 -21.95%
Dec 31, 2022 -19.34%
Sep 30, 2022 -20.76%
Jun 30, 2022 -23.16%
Mar 31, 2022 -19.65%
Dec 31, 2021 -15.48%
API Access

Edgewise Therapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=EWTX&period=max&api_key=YOUR_API_KEY